Go Pro

ICU Medical (ICUI) Competitors

ICU Medical logo
$184.56 0.00 (0.00%)
Closing price 08/7/2026 04:00 PM Eastern
Extended Trading
$184.54 -0.02 (-0.01%)
As of 06:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ICUI vs. SOLV, COO, ALGN, BLCO, and MMSI

Should you buy ICU Medical stock or one of its competitors? MarketBeat compares ICU Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with ICU Medical include Solventum (SOLV), Cooper Companies (COO), Align Technology (ALGN), Bausch + Lomb (BLCO), and Merit Medical Systems (MMSI). These companies are all part of the "healthcare supplies" industry.

How does ICU Medical compare to Solventum?

ICU Medical (NASDAQ:ICUI) and Solventum (NYSE:SOLV) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, risk, analyst recommendations, valuation, institutional ownership, profitability, earnings and dividends.

In the previous week, Solventum had 8 more articles in the media than ICU Medical. MarketBeat recorded 37 mentions for Solventum and 29 mentions for ICU Medical. ICU Medical's average media sentiment score of 0.81 beat Solventum's score of 0.70 indicating that ICU Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ICU Medical
12 Very Positive mention(s)
4 Positive mention(s)
9 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Solventum
14 Very Positive mention(s)
4 Positive mention(s)
13 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

96.1% of ICU Medical shares are held by institutional investors. 2.1% of ICU Medical shares are held by insiders. Comparatively, 0.2% of Solventum shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Solventum has a net margin of 17.26% compared to ICU Medical's net margin of 1.39%. Solventum's return on equity of 25.09% beat ICU Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
ICU Medical1.39% 7.91% 4.17%
Solventum 17.26%25.09%8.78%

Solventum has higher revenue and earnings than ICU Medical. Solventum is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ICU Medical$2.16B2.14$730K$1.18156.41
Solventum$8.33B1.70$1.56B$8.1810.15

ICU Medical presently has a consensus price target of $192.80, suggesting a potential upside of 4.46%. Solventum has a consensus price target of $91.64, suggesting a potential upside of 10.41%. Given Solventum's higher probable upside, analysts plainly believe Solventum is more favorable than ICU Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ICU Medical
0 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
2 Strong Buy rating(s)
2.89
Solventum
1 Sell rating(s)
5 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.46

ICU Medical has a beta of 0.74, meaning that its share price is 26% less volatile than the broader market. Comparatively, Solventum has a beta of 0.6, meaning that its share price is 40% less volatile than the broader market.

Summary

Solventum beats ICU Medical on 9 of the 17 factors compared between the two stocks.

How does ICU Medical compare to Cooper Companies?

Cooper Companies (NASDAQ:COO) and ICU Medical (NASDAQ:ICUI) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, earnings, media sentiment, dividends, profitability and analyst recommendations.

24.4% of Cooper Companies shares are held by institutional investors. Comparatively, 96.1% of ICU Medical shares are held by institutional investors. 2.1% of Cooper Companies shares are held by insiders. Comparatively, 2.1% of ICU Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, ICU Medical had 14 more articles in the media than Cooper Companies. MarketBeat recorded 29 mentions for ICU Medical and 15 mentions for Cooper Companies. Cooper Companies' average media sentiment score of 1.17 beat ICU Medical's score of 0.81 indicating that Cooper Companies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cooper Companies
9 Very Positive mention(s)
4 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
ICU Medical
12 Very Positive mention(s)
4 Positive mention(s)
9 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Cooper Companies currently has a consensus price target of $81.36, indicating a potential upside of 9.60%. ICU Medical has a consensus price target of $192.80, indicating a potential upside of 4.46%. Given Cooper Companies' higher probable upside, equities research analysts plainly believe Cooper Companies is more favorable than ICU Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cooper Companies
3 Sell rating(s)
6 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.35
ICU Medical
0 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
2 Strong Buy rating(s)
2.89

Cooper Companies has a net margin of 5.57% compared to ICU Medical's net margin of 1.39%. Cooper Companies' return on equity of 10.88% beat ICU Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Cooper Companies5.57% 10.88% 7.27%
ICU Medical 1.39%7.91%4.17%

Cooper Companies has a beta of 0.83, meaning that its share price is 17% less volatile than the broader market. Comparatively, ICU Medical has a beta of 0.74, meaning that its share price is 26% less volatile than the broader market.

Cooper Companies has higher revenue and earnings than ICU Medical. Cooper Companies is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cooper Companies$4.09B3.54$374.90M$1.1862.91
ICU Medical$2.16B2.14$730K$1.18156.41

Summary

Cooper Companies beats ICU Medical on 10 of the 16 factors compared between the two stocks.

How does ICU Medical compare to Align Technology?

ICU Medical (NASDAQ:ICUI) and Align Technology (NASDAQ:ALGN) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and profitability.

96.1% of ICU Medical shares are held by institutional investors. Comparatively, 88.4% of Align Technology shares are held by institutional investors. 2.1% of ICU Medical shares are held by company insiders. Comparatively, 0.8% of Align Technology shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, ICU Medical had 18 more articles in the media than Align Technology. MarketBeat recorded 29 mentions for ICU Medical and 11 mentions for Align Technology. Align Technology's average media sentiment score of 1.50 beat ICU Medical's score of 0.81 indicating that Align Technology is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ICU Medical
12 Very Positive mention(s)
4 Positive mention(s)
9 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Align Technology
8 Very Positive mention(s)
3 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

ICU Medical currently has a consensus price target of $192.80, suggesting a potential upside of 4.46%. Align Technology has a consensus price target of $206.36, suggesting a potential upside of 18.83%. Given Align Technology's higher probable upside, analysts plainly believe Align Technology is more favorable than ICU Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ICU Medical
0 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
2 Strong Buy rating(s)
2.89
Align Technology
0 Sell rating(s)
6 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.67

Align Technology has a net margin of 9.99% compared to ICU Medical's net margin of 1.39%. Align Technology's return on equity of 15.86% beat ICU Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
ICU Medical1.39% 7.91% 4.17%
Align Technology 9.99%15.86%10.32%

ICU Medical has a beta of 0.74, suggesting that its share price is 26% less volatile than the broader market. Comparatively, Align Technology has a beta of 1.65, suggesting that its share price is 65% more volatile than the broader market.

Align Technology has higher revenue and earnings than ICU Medical. Align Technology is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ICU Medical$2.16B2.14$730K$1.18156.41
Align Technology$4.03B3.08$410.35M$5.7530.20

Summary

Align Technology beats ICU Medical on 11 of the 17 factors compared between the two stocks.

How does ICU Medical compare to Bausch + Lomb?

ICU Medical (NASDAQ:ICUI) and Bausch + Lomb (NYSE:BLCO) are both mid-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, dividends, risk, institutional ownership, analyst recommendations, media sentiment, earnings and profitability.

ICU Medical currently has a consensus price target of $192.80, suggesting a potential upside of 4.46%. Bausch + Lomb has a consensus price target of $18.75, suggesting a potential upside of 12.04%. Given Bausch + Lomb's higher possible upside, analysts plainly believe Bausch + Lomb is more favorable than ICU Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ICU Medical
0 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
2 Strong Buy rating(s)
2.89
Bausch + Lomb
1 Sell rating(s)
8 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.29

ICU Medical has higher earnings, but lower revenue than Bausch + Lomb. Bausch + Lomb is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ICU Medical$2.16B2.14$730K$1.18156.41
Bausch + Lomb$5.10B1.17-$360M-$0.48N/A

In the previous week, ICU Medical had 10 more articles in the media than Bausch + Lomb. MarketBeat recorded 29 mentions for ICU Medical and 19 mentions for Bausch + Lomb. ICU Medical's average media sentiment score of 0.81 beat Bausch + Lomb's score of 0.34 indicating that ICU Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ICU Medical
12 Very Positive mention(s)
4 Positive mention(s)
9 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Bausch + Lomb
6 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

96.1% of ICU Medical shares are held by institutional investors. Comparatively, 11.1% of Bausch + Lomb shares are held by institutional investors. 2.1% of ICU Medical shares are held by company insiders. Comparatively, 1.5% of Bausch + Lomb shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

ICU Medical has a net margin of 1.39% compared to Bausch + Lomb's net margin of -3.21%. ICU Medical's return on equity of 7.91% beat Bausch + Lomb's return on equity.

Company Net Margins Return on Equity Return on Assets
ICU Medical1.39% 7.91% 4.17%
Bausch + Lomb -3.21%4.14%1.93%

ICU Medical has a beta of 0.74, suggesting that its stock price is 26% less volatile than the broader market. Comparatively, Bausch + Lomb has a beta of 0.55, suggesting that its stock price is 45% less volatile than the broader market.

Summary

ICU Medical beats Bausch + Lomb on 14 of the 17 factors compared between the two stocks.

How does ICU Medical compare to Merit Medical Systems?

ICU Medical (NASDAQ:ICUI) and Merit Medical Systems (NASDAQ:MMSI) are both mid-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, valuation, dividends, institutional ownership, earnings and media sentiment.

ICU Medical presently has a consensus price target of $192.80, indicating a potential upside of 4.46%. Merit Medical Systems has a consensus price target of $100.30, indicating a potential upside of 12.65%. Given Merit Medical Systems' higher possible upside, analysts plainly believe Merit Medical Systems is more favorable than ICU Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ICU Medical
0 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
2 Strong Buy rating(s)
2.89
Merit Medical Systems
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.73

ICU Medical has a beta of 0.74, suggesting that its share price is 26% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.48, suggesting that its share price is 52% less volatile than the broader market.

96.1% of ICU Medical shares are owned by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are owned by institutional investors. 2.1% of ICU Medical shares are owned by company insiders. Comparatively, 0.7% of Merit Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, ICU Medical had 20 more articles in the media than Merit Medical Systems. MarketBeat recorded 29 mentions for ICU Medical and 9 mentions for Merit Medical Systems. ICU Medical's average media sentiment score of 0.81 beat Merit Medical Systems' score of 0.76 indicating that ICU Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ICU Medical
12 Very Positive mention(s)
4 Positive mention(s)
9 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Merit Medical Systems
5 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Merit Medical Systems has lower revenue, but higher earnings than ICU Medical. Merit Medical Systems is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ICU Medical$2.16B2.14$730K$1.18156.41
Merit Medical Systems$1.52B3.51$128.49M$2.4236.79

Merit Medical Systems has a net margin of 9.22% compared to ICU Medical's net margin of 1.39%. Merit Medical Systems' return on equity of 13.75% beat ICU Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
ICU Medical1.39% 7.91% 4.17%
Merit Medical Systems 9.22%13.75%8.10%

Summary

Merit Medical Systems beats ICU Medical on 9 of the 17 factors compared between the two stocks.

Get ICU Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ICUI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ICUI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ICUI vs. The Competition

MetricICU MedicalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$4.61B$5.76B$7.00B$12.99B
Dividend YieldN/A1.78%2.58%10.20%
P/E Ratio156.4124.26270.5825.05
Price / Sales2.1468.46658.42107.93
Price / Cash12.6633.5528.8937.44
Price / Book2.156.1111.186.43
Net Income$730K$149.01M$3.45B$348.10M
7 Day Performance6.72%2.35%3.39%2.66%
1 Month Performance19.52%0.62%-0.71%-0.85%
1 Year Performance63.54%4.91%77.30%23.96%

ICU Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ICUI
ICU Medical
2.8546 of 5 stars
$184.56
flat
$192.80
+4.5%
+63.5%$4.61B$2.16B156.4113,000
SOLV
Solventum
3.1648 of 5 stars
$87.68
-0.4%
$86.00
-1.9%
+13.2%$15.15B$8.33B10.7220,000
COO
Cooper Companies
3.146 of 5 stars
$73.43
-1.1%
$81.36
+10.8%
+5.6%$14.44B$4.09B62.7515,000
ALGN
Align Technology
3.7098 of 5 stars
$171.50
-0.8%
$206.36
+20.3%
+24.1%$12.34B$4.03B29.9720,290
BLCO
Bausch + Lomb
3.5606 of 5 stars
$16.77
0.0%
$18.75
+11.8%
+22.4%$5.99B$5.10BN/A13,000

Related Companies and Tools


This page (NASDAQ:ICUI) was last updated on 8/10/2026 by MarketBeat.com Staff.
From Our Partners